- Home
- / Silk Road Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Silk Road Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$27.5
2024-09-26
Market Capitalization
$1.1 B
2024-09-26
Revenue
$177.1 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 14.3M | 34.6M | 63.4M | 75.2M | 101.5M | 138.6M | 177.1M |
| Revenue growth, % | 142.4% | ||||||
| Cost of goods sold | 5.1M | 10.9M | 15.9M | 21.3M | 25.4M | 37.9M | 50.0M |
| Gross profit | 9.1M | 23.7M | 47.4M | 53.9M | 76.0M | 100.8M | 127.1M |
| Gross profit margin, % | 64.0% | 68.5% | 74.9% | 71.7% | 72.7% | 71.7% | |
| General and administrative expense | 20.3M | 34.8M | 63.2M | 75.5M | 96.4M | 116.3M | 145.0M |
| Operating expense total | 27.5M | 45.1M | 75.5M | 96.8M | 123.5M | 152.8M | 186.4M |
| EBIT | (18.4M) | (21.4M) | (28.1M) | (42.9M) | (47.5M) | (52.0M) | (59.3M) |
| EBIT margin, % | -128.9% | -61.9% | -44.3% | -57.0% | -37.5% | -33.5% | |
| Interest income | 34.0K | 189.0K | 1.7M | 1.1M | 198.0K | 2.5M | 10.0M |
| Interest expense | 3.9M | 4.4M | 6.9M | ||||
| Pre tax profit | (52.4M) | (47.4M) | (49.8M) | (55.0M) | (55.7M) | ||
| Income tax expense | 8.0K | 11.0K | 20.0K | 29.0K | 43.0K | ||
| Net Income | (19.4M) | (37.6M) | (52.4M) | (47.4M) | (49.8M) | (55.0M) | (55.7M) |
| EPS | (1.5) | (1.4) |